Psychiatry Pathways

Assessment and pharmacological management of first-episode and relapse psychosis

Stepped-care model for depression — talking therapies, antidepressants, and augmentation

Lithium initiation, therapeutic monitoring, and toxicity management

CIWA-Ar scoring, benzodiazepine regimen, and Wernicke's prophylaxis

Medical risk stratification in anorexia nervosa and management pathway

NICE NG185 — distinguish acute mania / depression / mixed / euthymia, mood stabilisers, address psychosocial.

NICE CG113 stepped care — psychoeducation → low-intensity → high-intensity (CBT) → SSRI.

NICE CG31 — stepped care, exposure + response prevention CBT, SSRI / clomipramine, longer treatment durations than depression.

NICE NG116 — trauma-focused CBT or EMDR first-line, SSRI/venlafaxine if not effective, screen for comorbidity.

MHA 1983 (amended 2007) — sections 2 / 3 / 4 / 5 / 136 / 135 — when each applies, lawful procedure, rights.

NICE NG225 — comprehensive psychosocial assessment; do NOT use risk stratification tools as basis for management; focus on safety planning.

NICE NG87 — DSM-5 / ICD-11 criteria, structured interview (DIVA), exclude differentials, multimodal management (psychostimulants + non-pharm).

NICE CG142 — recognition, autism diagnostic instruments (ADOS, AAA, RAADS-R), comprehensive assessment, support not 'cure'.

NICE CG78 — psychological therapy first-line (DBT, MBT, schema-focused), avoid medication for primary symptoms, manage crisis, treat comorbidity.

NICE CG192 — antenatal + postnatal mental illness, suicide leading cause of maternal death, urgent assessment, drug safety in pregnancy / breastfeeding.

Opioid substitution therapy (methadone / buprenorphine), naloxone provision, harm reduction, comorbidity.

NICE NG215 / CKS — diagnose, exclude secondary causes, CBT-I first-line, pharmacotherapy short-term only.